Evaluation of the VERSAJET II Hydrosurgery System at Krasnogorsk Clinical Hospital

An evaluation of the VERSAJET II hydrosurgery system by Smith&Nephew was conducted in the Department of Purulent Surgery at Krasnogorsk Clinical Hospital (Moscow Region).

VERSAJET II is a hydrosurgical wound debridement system based on a high-velocity saline jet technology. This approach enables selective and precise removal of non-viable tissue, bacterial contamination, and debris, while preserving as much viable tissue as possible within the wound bed.

In purulent surgery, this technology is particularly important, as it provides not only mechanical wound cleansing but also controlled and tissue-sparing debridement with minimal trauma to surrounding structures.

Key features of the VERSAJET II system

• Tissue-preserving technology that reduces the need for extensive excision;
• Selective removal of non-viable tissue;
• Creation of a cleaner and more uniform wound bed;
• Applicability in acute and chronic wounds, burns, and soft tissue injuries.

The use of hydrosurgical debridement may improve treatment outcomes, reduce healing time, and optimize overall treatment costs due to more precise and controlled wound management.

Clinical evaluations such as this make it possible to assess the practical effectiveness of the equipment and determine how hydrosurgical technologies can be integrated into the workflow of surgical departments managing complex wounds.